Report cover image

Single-use Bioreactors Market - By Product (Stirred Tank, Wave-mixed, Bubble Column), Cell (Mammalian, Bacterial, Yeast), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins), Usage, End-use- Global Forecast, 2023-2032

Publisher Global Market Insights
Published Oct 10, 2023
Length 199 Pages
SKU # GMI18380656

Description

Single-use Bioreactors Market - By Product (Stirred Tank, Wave-mixed, Bubble Column), Cell (Mammalian, Bacterial, Yeast), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins), Usage, End-use- Global Forecast, 2023-2032


Global Single-use Bioreactors Market will register a 15.5% CAGR from 2023 to 2032, propelled by the remarkable advancements in healthcare and the inherent flexibility of single-use bioprocessing technologies. The increasing demand for biopharmaceuticals, driven by a surge in precision medicine and therapeutic innovations, underscores the significance of these advancements. Single-use bioreactors, owing to their adaptable and cost-effective nature, emerge as pivotal tools in meeting the evolving needs of the healthcare sector, thereby significantly contributing to the industry landscape.

For instance, in 2023, Getinge launched the AppliFlex ST GMP, an innovative single-use bioreactor system crafted to smoothly connect the realms of research and clinical production in cell and gene therapy, along with mRNA production. This launch bolsters the market share by seamlessly integrating cutting-edge healthcare advancements and the intrinsic flexibility of single-use bioprocessing technologies.

The single-use bioreactors market is segregated based on molecule, cell, and region.

The monoclonal antibodies (mAbs) segment will garner substantial gains through 2032. This prominence stems from the increasing therapeutic applications of mAbs, particularly in treating cancer and autoimmune diseases. Their high specificity, therapeutic efficacy, and rising demand for personalized medicine contribute to their prominence in bioprocessing. As the pharmaceutical landscape prioritizes precision and targeted therapies, the role of monoclonal antibodies within single-use bioreactors becomes pivotal, shaping the bioreactors market outlook.

The bacterial cell segment will capture a remarkable revenue share by 2032 due to the widespread application of bacterial cells in various bioprocessing activities, including the production of vaccines, enzymes, and biotherapeutics. The versatility, scalability, and cost-effectiveness of utilizing bacterial cells contribute to their prominence. As the demand for biopharmaceuticals continues to escalate, the prevalence of bacterial cell-based processes will position them as a pivotal driver in carving a healthy market growth trajectory.

APAC single-use bioreactors market size will expand at a notable CAGR from 2023 to 2032, fueled by a confluence of factors, including the growing demand for biopharmaceuticals, increasing investments in research and development, and a burgeoning biotechnology sector. Favorable regulatory environments, in line with the region's robust manufacturing capabilities, contribute to its prominence. As the global pharmaceutical landscape continues to evolve, the Asia-Pacific market stands as a key contributor, driving innovation and shaping the future of single-use bioreactors.

Table of Contents

199 Pages
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global single-use bioreactors market 360 degree synopsis, 2018 - 2032
2.2 Regional trends
2.3 Product trends
2.4 Cell trends
2.5 Molecule trends
2.6 Usage trends
2.7 End-use trends
Chapter 3 Single-use Bioreactors Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Growing pharmaceutical and biotechnology industry
3.5.1.2 Technological advancements in single-use bioreactors
3.5.1.3 Growing focus on orphan drug development
3.5.1.4 Rising demand for personalized medicines
3.5.2 Industry pitfalls & challenges
3.5.2.1 Low capacity of single-use bioreactors
3.5.2.2 Concerns regarding extractables and/or leachables
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By cell
3.6.3 By molecule
3.6.4 By usage
3.6.5 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Thermo Fisher Scientific Inc.
4.1.2 Danaher Corporation
4.1.3 Merck KGaA
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Single-use Bioreactors Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Stirred tank single-use bioreactors
5.3 Wave-mixed single-use bioreactors
5.4 Bubble column single-use bioreactors
5.5 Other products
Chapter 6 Single-use Bioreactors Market Size and Forecast, By Cell , 2018-2032 (USD Million)
6.1 Key trends, by cell
6.2 Mammalian cells
6.3 Bacterial cells
6.4 Yeast cells
6.5 Other cells
Chapter 7 Single-use Bioreactors Market Size and Forecast, By Molecule, 2018-2032 (USD Million)
7.1 Key trends, by molecule
7.2 Monoclonal antibodies
7.3 Vaccines
7.4 Recombinant proteins
7.5 Stem cells
7.6 Gene therapy
7.7 Other molecules
Chapter 8 Single-use Bioreactors Market Size and Forecast, By Usage, 2018-2032 (USD Million)
8.1 Key trends, by usage
8.2 Developmental, pre-clinical & clinical
8.3 Commercial production
Chapter 9 Single-use Bioreactors Market Size and Forecast, By End-use, 2018-2032 (USD Million)
9.1 Key trends, by end-use
9.2 R&D organizations
9.3 Biopharma manufacturers
9.4 Contract manufacturing organizations
Chapter 10 Single-use Bioreactors Market Size and Forecast, By Region, 2018-2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Denmark
10.3.8 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Singapore
10.4.7 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 UAE
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Thermo Fisher Scientific
11.2 Solaris Biotech Solutions
11.3 Shanghai Bailun Biotechnology Co. Ltd.
11.4 Sartorius Stedim Biotech Group
11.5 Pierre Guerin Sas (Engie)
11.6 PBS Biotech
11.7 Danaher Corporation
11.8 Merck Group
11.9 GEA Group Aktiengesellschaft
11.10 Eppendorf AG
11.11 CESCO Bioengineering Co. Ltd.
11.12 CerCell ApS
11.13 Cellexus Ltd
11.14 Bbi Biotech
11.15 Applikon Biotechnology, Inc. (Getinge)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us